WALID FAWAZ: Open Payments
NPI 1477714111 · HOPEWELL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 8 payments from 7 companies in 2025. Trend: 2023 $123 · 2024 $216 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Indivior Inc. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| TMS NeuroHealth Centers Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: COBENFY, SUBLOCADE, INGREZZA, TMS NeuroHealth Centers Inc., Jornay PM, AUSTEDO XR, TRINTELLIX.
Industry payments across VA — which companies pay providers there.
